Authors
Lopez-Cruz, A., Burgos, N. S. F., Hakimi, A. M., Xie, K., Mao, M., Kaur, M., Spina, A., Choi, K., Qui, L., Lever, T. E., Gribble, F. M., Reimann, F., Myers, M. G., Adriaenssens, A. E., Knight, Z. A.
Abstract
Nausea arises from activation of specialized neurons in the area postrema (AP). The AP also mediates much of the satiety produced by GLP1R agonists, suggesting a broader role in non-aversive physiology, yet the functions of AP cell types are not well understood. Here, we have used optical recordings in behaving mice to systematically define the natural regulation of an array of AP neurons, including the cell types that are principal targets of widely-used weight loss drugs. We discover that neurons expressing GFRAL, the receptor for the sickness-related hormone GDF15, are unexpectedly activated when mice consume food rich in fat. This fat-specific GFRAL neuron activation is required for fat satiation but does not involve GDF15 or canonical gut-brain pathways. Instead, anti-nausea neurons expressing GIPR, which directly inhibit GFRAL neurons, are selectively activated by sugar, enabling macronutrient-specific gating of GFRAL responses. In addition, we show that CALCR neurons link intestinal hyperosmolality to the suppression of feeding, whereas PRLHR neurons respond to changes in blood volume and pressure. These findings reveal a broad role for AP cell types in sensing and responding to physiologic signals unrelated to nausea. They also reveal that GFRAL and GIPR neurons, which are key targets of the weight-loss drug tirzepatide, have a natural function in sensing ingestion of fat and sugar, respectively.
Preprint server:
bioRxiv
The authors list and abstract were imported from bioRxiv on 20 Jun 2026.
Advertisement
Stats
- Recommendations n/a n/a positive of 0 vote(s)
- Views 0
- Comments 0